Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_assertion type Assertion NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_head.
- NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_assertion description "[Use of the activating gene mutation of the tyrosine kinase (VAL617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis and myeloid metaplasia after allogeneic stem cell transplantation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_provenance.
- NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_assertion evidence source_evidence_literature NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_provenance.
- NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_assertion SIO_000772 17565328 NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_provenance.
- NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_assertion wasDerivedFrom befree-20140225 NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_provenance.
- NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_assertion wasGeneratedBy ECO_0000203 NP486478.RA30pIETAsrqhReqeXsK6z9_qHMQlzysimlZKxe7xaFJY130_provenance.